Recent Updates
Recently added Catalysts
AKBA Positive Sentiment Score: 70/100

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025

Wednesday, May 28, 2025 1 min read
Key Takeaway: Akebia Therapeutics announced that its Executive Management will participate in a Fireside Chat at the Jefferies Global Healthcare Conference on June 5, 2025. This conference, held in New York City from June 3-5, aims to bring together various stakeholders in the healthcare sector. A webcast of the presentation will be available on Akebia's website. The company focuses on improving the lives of people impacted by kidney disease.

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia's participation at the Jefferies Global Healthcare Conference highlights its active engagement in the healthcare community.
  • The company aims to improve the lives of individuals affected by kidney disease, showcasing a strong mission.
  • The event provides a platform for Akebia to connect with investors and stakeholders, potentially enhancing its visibility.

Full Press Release Details

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management will participate in a Fireside Chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 8:45 AM EDT.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The Jefferies Global Healthcare Conference will take place June 3-5, 2025, in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
mcarrasco@akebia.com

Frequently Asked Questions

When will Akebia participate in the Jefferies Conference?

Akebia will participate in the Jefferies Global Healthcare Conference on June 5, 2025.

How can I access the webcast of Akebia's presentation?

The webcast can be accessed in the 'Investors' section of Akebia’s website.

Where is Akebia Therapeutics headquartered?

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.

What is Akebia's main focus as a biopharmaceutical company?

Akebia aims to improve the lives of individuals affected by kidney disease.

Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics kidney disease Jefferies Global Healthcare Conference healthcare Nasdaq AKBA
Last updated: May 28, 2025

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London